TCF3 and acute promyelocytic leukemia: All-trans retinoic acid can achieve therapeutic effects in acute promyelocytic leukemia (APL) cell lines and primary patient cells by rapidly increasing ID1 expression and downregulating TCF3, leading to G0/G1 cell-cycle arrest [71].